PCLCX
Price
$17.20
Change
+$0.03 (+0.17%)
Updated
Jun 2 closing price
Net Assets
721.87M
RGAGX
Price
$88.82
Change
-$0.29 (-0.33%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

PCLCX vs RGAGX

Header iconPCLCX vs RGAGX Comparison
Open Charts PCLCX vs RGAGXBanner chart's image
PCLCX vs RGAGX Comparison Chart in %
View a ticker or compare two or three
VS
PCLCX vs. RGAGX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLCX is a Buy and RGAGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 338B vs. PCLCX (722M). RGAGX pays higher dividends than PCLCX: RGAGX (0.51) vs PCLCX (0.01). PCLCX was incepted earlier than RGAGX: PCLCX (31 years) vs RGAGX (17 years). PCLCX (0.91) is less costly to investors than RGAGX (0.29). PCLCX is a more actively managed with annual turnover of: 69.00 vs. RGAGX (32.00). RGAGX has a lower initial minimum investment than PCLCX: RGAGX (250) vs PCLCX (10000). RGAGX annual gain was more profitable for investors over the last year : 15.41 vs. PCLCX (-5.02). RGAGX return over 5 years is better than : 27.14 vs. PCLCX (-39.61).
PCLCXRGAGXPCLCX / RGAGX
Total Expense Ratio0.880.29303%
Annual Report Gross Expense Ratio0.910.29314%
Fund Existence31 years17 years-
Gain YTD4.44010.59942%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets722M338B0%
Annual Yield % from dividends0.010.512%
Returns for 1 year-5.0215.41-33%
Returns for 3 years21.7855.3139%
Returns for 5 years-39.6127.14-146%
Returns for 10 years-22.33117.06-19%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCITX31.20N/A
N/A
Victory Pioneer International Equ C
MITTX38.39N/A
N/A
MFS Massachusetts Investors Tr A
MSCYX15.29N/A
N/A
MassMutual Small Cap Gr Eq Svc
TNXIX23.50N/A
N/A
1290 Avantis U.S. Large Cap Growth I
FAPJX14.31N/A
N/A
Fidelity Advisor Healthy Future A